Thermo Fisher Scientific (TMO) Stock Price & Analysis

TMO$700.22+0.78 +0.11%
Medical - Diagnostics & ResearchMega Cap
Compare
Market cap$259.44BEnterprise value$297.55BRevenue (TTM)$47.35BMarket positionTop 5%

Score

38
Bearish
Value
23
Quality
52
Growth
38

AI Analysis

Snapshot

Thermo Fisher Scientific doesn’t screen as a clean setup today — Stocklytics 38/100 leaves more to prove. Under the hood: P/E 37.2.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

23
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

38
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

52
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Thermo Fisher Scientific Inc. (TMO) last printed $700.22. Equity value is $259.44B. Trailing earnings multiple 36.63. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$18.27B$20.92B$24.36B$25.54B$32.22B$39.21B$44.91B$42.86B$42.88B$44.56B

About

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific (TMO) Stock Price & Analysis

TMO price $700.22 +0.78 +0.11%

Ticker
TMO
Price
$700.22
Change
+0.78 +0.11%
Market cap
$259.44B
P/E
36.63
Forward P/E
25.98
Dividend yield
0.26%
Beta
0.84
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
38
Value
23
Quality
52
Growth
38

Stocklytics score rationale: value 23, quality 52, growth 38.

AI Score 85. Thermo Fisher Scientific Inc. has a strong market capitalization of $257.7 billion and a solid net profit margin of approximately 15%

Summary

Thermo Fisher Scientific Inc. operates in Healthcare, within Medical - Diagnostics & Research. The company reports a net margin of 15.0% and a dividend yield of 0.3%.

Valuation

The shares trade at a P/E ratio of 37.2 and a price-to-book ratio of 4.8. These valuation measures provide limited context without growth, estimate, or price-trend data.

Quality

A net margin of 15.0% indicates the company retains profit after expenses. Additional balance-sheet, cash-flow, and return metrics are not provided.

Growth

No revenue, earnings-growth, or analyst-estimate figures are provided. Growth cannot be assessed from the available facts.

Risks

The P/E ratio of 37.2 and price-to-book ratio of 4.8 may leave the shares sensitive to changes in earnings expectations. No price-trend or forecast data is provided.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener